News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,285 Results
Type
Article (26387)
Company Profile (60)
Press Release (367836)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104463)
Career Advice (455)
Deals (16900)
Drug Delivery (53)
Drug Development (47772)
Employer Resources (47)
FDA (12357)
Job Trends (8491)
News (186491)
Policy (19534)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1770)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26853)
ALS (97)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12690)
Artificial intelligence (303)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6899)
BIOSECURE Act (5)
Biosimilars (74)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3062)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42966)
Collaboration (850)
Compensation (271)
Complete response letters (16)
COVID-19 (1557)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4226)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3714)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38662)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54234)
Executive appointments (584)
FDA (14632)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (752)
Gene editing (75)
Generative AI (20)
Gene therapy (261)
GLP-1 (541)
Government (3142)
Grass and pollen (4)
Guidances (229)
Healthcare (12213)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1688)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (119)
Interviews (40)
IPO (7076)
IRA (23)
Job creations (1846)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3648)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (289)
MASH (105)
Medical device (13311)
Medtech (13356)
Mergers & acquisitions (10338)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1689)
NextGen: Class of 2026 (3937)
Non-profit (2839)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (149)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (350)
Peanut (42)
People (35648)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12350)
Phase 2 (18581)
Phase 3 (15271)
Pipeline (3031)
Policy (125)
Postmarket research (1670)
Preclinical (3806)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2870)
Recruiting (18)
Regulatory (15694)
Reports (18)
Research institute (1656)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2136)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (503)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Last 7 days (303)
Last 30 days (1101)
Last 365 days (16147)
2026 (1473)
2025 (16494)
2024 (19866)
2023 (22750)
2022 (30704)
2021 (33006)
2020 (32217)
2019 (28456)
2018 (21842)
2017 (18928)
2016 (18154)
2015 (21230)
2014 (16035)
2013 (13269)
2012 (14380)
2011 (14677)
2010 (13202)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (176)
Arkansas (10)
Asia (25514)
Australia (4034)
California (5570)
Canada (1905)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49989)
Florida (953)
Georgia (239)
Hawaii (1)
Idaho (35)
Illinois (579)
India (32)
Indiana (376)
Iowa (11)
Japan (315)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3743)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1921)
New Mexico (10)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2645)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (524)
South Carolina (59)
Southern California (2235)
Tennessee (124)
Texas (1017)
United States (21626)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,285 Results for "volta medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Volta Medical’s RESTART Trial Shows Promising Findings for AI Solutions in Recurrent Atrial Fibrillation
February 3, 2026
·
5 min read
Press Releases
Volta Medical Announces U.S. Label Expansion for Volta AF-Xplorer™ to Include Pivotal TAILORED-AF Clinical Trial Data
June 11, 2025
·
5 min read
Press Releases
Volta Medical Announces Presentations at Heart Rhythm Society 2025 in San Diego, CA, USA
April 15, 2025
·
5 min read
Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
Volta Medical today announced presentations to be made at the Heart Rhythm Society 2024 meeting in Boston, May 16 to 19. In-person attendance and live online participation in a hybrid format will be available.
April 18, 2024
·
4 min read
Volta Medical Receives CE Mark for AF-Xplorer™ Decision support solution to Simplify Complex Atrial Fibrillation Procedures
Volta Medical today announced CE (Conformité Européenne) Mark according to the new European Medical Device Regulation MDR 2017/745 for its Volta AF-Xplorer™, an AI companion that is cleared in the United States for the real-time manual or automatic annotation of spatiotemporal dispersions during AF and atrial tachycardia (AT) procedures.
February 28, 2024
·
4 min read
Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation patients
Volta Medical announced positive results from the transatlantic, multicenter, randomized, controlled, superiority trial titled Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation (TAILORED-AF) at Heart Rhythm 2024 Late Breaking Clinical Trials and Science program.
May 20, 2024
·
4 min read
Business
Volta Labs and Element Biosciences Announce Collaboration to Enable Walk-Away Sample Prep and Sequencing on the AVITI™ System
Volta Labs and Element Biosciences, Inc. today announced a collaboration to optimize sequencing throughput with the launch of Volta’s Callisto™ Sample Prep System for Element’s AVITI.
February 7, 2024
·
2 min read
Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation
Volta Medical today announced initiation of Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion (RESTART), an interventional clinical trial to be conducted at 16 US and 5 EU sites, evaluating the use of Volta’s AI ablation solution in recurrent-AF patients who failed previous ablations and are now undergoing Volta-supported ablation.
June 22, 2023
·
4 min read
Volta Medical Announces FDA Clearance of Volta AF-Xplorer™ Software to Simplify Complex Atrial Fibrillation Procedures
Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in treating complex cardiac arrhythmias such as atrial fibrillation (AF), today announced that the U.S. Food and Drug Administration (FDA) has cleared Volta AF-Xplorer™, an AI companion designed for the assessment of complex AF and atrial tachycardia (AT) procedures.
May 18, 2023
·
4 min read
Press Releases
UMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testing
February 6, 2025
·
3 min read
1 of 39,429
Next